Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost side effects from taking Wegovy are gastrointestinal, tend to be most noticeable in the first few weeks of treatment or after a dose increase, and settle for many people once their system adjusts. Wegovy (semaglutide) is a prescription-only medicine — a GLP-1 receptor agonist — and like any medicine it carries real risks alongside its benefits. The NHS semaglutide medicines page lists the full side-effect profile, and this page walks through what the pattern typically looks like, which symptoms to watch closely, and which ones need urgent medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting dose of Wegovy is 0.25 mg, and its job is to let your body get used to semaglutide gradually before the dose moves up. Nausea is the most frequently reported effect at this stage. For some people it is mild and passes quickly; for others it is more disruptive, particularly in the day or two after each injection. Vomiting, loose stools and indigestion also appear on the common list.
Fatigue and mild headache turn up less often but are reported enough to be worth knowing about. Injection-site reactions (redness, mild swelling or itching at the abdomen, thigh or upper arm) are generally short-lived and tend to reduce with good technique and rotating the injection site each week.
The honest answer is that the first few weeks can feel rough. If you are reading this because you are currently in that phase and wondering whether to push through, that experience is not unusual and it does not necessarily mean Wegovy is wrong for you. The Wegovy overview explains how the dose pathway works and what the medicine is actually doing during this adjustment period. Decisions about whether to slow the titration belong with your prescriber, not a patient forum.
Dehydration is a practical risk if nausea or vomiting is significant, small sips of water frequently, rather than large drinks, can help, and your prescriber should know if symptoms are severe enough to affect your fluid intake.
The Wegovy schedule moves through several dose steps before reaching the maintenance dose, with roughly four weeks at each level. A pattern many people notice: side effects that had settled at one dose can briefly return after a step up. This is normal and is the reason the titration exists at all, moving slowly is built into the design of the treatment.
Constipation can become more prominent at higher doses for some people, even if the early phase brought the opposite problem. Burping, reflux and a feeling of fullness that arrives unusually quickly are also reported more often at higher doses. These reflect how semaglutide slows gastric emptying, which is part of its mechanism for reducing appetite.
If you are on this treatment via a private pharmacy, it matters that a real clinician is overseeing the process. At nume, a GPhC-registered prescriber personally reviews every repeat order before it is dispensed, not because the rules require a box to be ticked, but because how you are tolerating the current dose is exactly the kind of thing a clinical review should catch. You can read more about our prescribers and how that process works on the clinical team page.
Side effects that are severe, persistent across multiple weeks at the same dose, or that affect your ability to eat and drink normally deserve a conversation with a clinician. Do not simply wait for the next scheduled review if symptoms are distressing.
Most Wegovy side effects are uncomfortable rather than dangerous. A few are not. Know these before you start.
Pancreatitis. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis. The warning sign is severe, persistent pain in the stomach area that may spread to the back, sometimes with vomiting. This is not the ordinary nausea of the first week. Stop taking Wegovy and seek urgent medical help if this happens. If you want to understand what a side effect from Wegovy looks like when it requires urgent attention, that page covers the distinction clearly alongside official reporting guidance. Side effects including suspected pancreatitis should also be reported on the Yellow Card site.
Severe dehydration or kidney problems can follow serious vomiting or diarrhoea. Signs include passing very little urine, dizziness on standing, or extreme thirst alongside no improvement in symptoms, these need medical assessment.
Allergic reactions (rash, difficulty breathing, swelling of the face, lips or throat) require immediate emergency care.
Gallbladder problems are flagged in the safety data: new or worsening pain in the upper right abdomen, particularly after eating, should be discussed with a doctor.
For a broader look at how semaglutide's side-effect profile compares to other weight-management medicines, the semaglutide side effects page covers the class picture in more detail. The NHS England weight management injections guidance also sets out safety information relevant to anyone starting this treatment.
Some people tolerate Wegovy well from the outset with very little disruption. That is a good outcome, not a sign that the medicine is not working. The guide on experiencing no side effects from Wegovy addresses this question directly, since it comes up often.
It is also worth knowing that individual responses vary significantly, genetics, gut motility, meal timing and other medicines all play a role. Our page on the side effects of taking Wegovy explores how these factors can shape what you personally experience, since the side-effect profile one person encounters tells you nothing reliable about what another person will encounter. Comparing notes on forums is natural but rarely useful for making decisions about your own treatment. That conversation belongs with whoever is prescribing for you.
If you are considering Wegovy and want to understand how suitability and side-effect risk are assessed at the consultation stage, our prescribers discuss exactly this during the free assessment, and the full breakdown of side effects from Wegovy is worth reading before you begin. You can start that process at the treatment page, or browse the FAQs if you have specific questions before getting started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.